AK
Ashok Kumar Agarwal
About Ashok Kumar Agarwal
Data last updated:
Ashok Kumar Agarwal is a Director at Safecon Lifesciences Private Limited (since 2022), Director at Wellcon Animal Health Private Limited (since 2022) and Director at Meek Pharma Private Limited (since 2005). The companies operate in Pharma. The 3 current companies with reported revenue have a combined latest revenue of ₹148 Cr; the largest is Safecon Lifesciences Private Limited at ₹87.00 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Safecon Lifesciences Private Limited U74999UP2016PTC083395 | Director | 22 Jun 2022 | 2016 | ₹87.00 Cr (FY 2025) | Active |
 Wellcon Animal Health Private Limited U33111UP2015PTC067989 | Director | 22 Jun 2022 | 2015 | ₹53.37 Cr (FY 2025) | Active |
 Meek Pharma Private Limited U24230UR2005PTC000876 | Director | 22 Aug 2005 | 2005 | ₹7.27 Cr (FY 2025) | Active |
Board colleagues of Ashok Kumar Agarwal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Akash Sharma | 10859681 | Safecon Lifesciences Private Limited , Wellcon Animal Health Private Limited and 1 more | Director |
| Anshul Agarwal | 06885646 | Safecon Lifesciences Private Limited , Meek Pharma Private Limited | Director |
| Ankur Agarwal | 00548259 | Wellcon Animal Health Private Limited , Meek Pharma Private Limited | Managing Director |
| Deepak Kumar Agarwal | 00917053 | Meek Pharma Private Limited | Director |
| Sachin Kumar Agrawal | 10730615 | Meek Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ashok Kumar Agarwal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ashok Kumar Agarwal
Ashok Kumar Agarwal currently holds 3 directorships: Safecon Lifesciences Private Limited (Director, since 22 Jun 2022, revenue ₹87.00 Cr (FY 2025)); Wellcon Animal Health Private Limited (Director, since 22 Jun 2022, revenue ₹53.37 Cr (FY 2025)); Meek Pharma Private Limited (Director, since 22 Aug 2005, revenue ₹7.27 Cr (FY 2025)).
Ashok Kumar Agarwal was first appointed on 22 Aug 2005 as Director at Meek Pharma Private Limited. The most recent appointment on record is 22 Jun 2022 at Wellcon Animal Health Private Limited.
The 3 current companies of Ashok Kumar Agarwal that report revenue have a combined latest revenue of ₹148 Cr: Safecon Lifesciences Private Limited ₹87.00 Cr (FY 2025); Wellcon Animal Health Private Limited ₹53.37 Cr (FY 2025); Meek Pharma Private Limited ₹7.27 Cr (FY 2025).
The current boards of Ashok Kumar Agarwal's companies include Akash Sharma (Safecon Lifesciences Private Limited), Anshul Agarwal (Safecon Lifesciences Private Limited), Ankur Agarwal (Wellcon Animal Health Private Limited), Deepak Kumar Agarwal (Meek Pharma Private Limited), Sachin Kumar Agrawal (Meek Pharma Private Limited).